197 related articles for article (PubMed ID: 24152637)
1. A hepatoid adenocarcinoma of the stomach evaluated with (18)F-FDG PET/CT: intense (18)F-FDG uptake contrary to the previous report.
Seo HJ; Chung JK; Go H; Cheon GJ; Lee DS
Clin Nucl Med; 2014 May; 39(5):442-5. PubMed ID: 24152637
[TBL] [Abstract][Full Text] [Related]
2. A hepatoid adenocarcinoma of the stomach with liver metastasis mimicking hepatocellular carcinoma detected by F-18 FDG PET/CT imaging.
Pan JH; Dong MJ; Ouyang XB
Clin Nucl Med; 2011 Dec; 36(12):1137-9. PubMed ID: 22064094
[No Abstract] [Full Text] [Related]
3. Should 18F-FDG PET/CT Be Routinely Performed in the Clinical Staging of Locally Advanced Gastric Adenocarcinoma?
Perlaza P; Ortín J; Pagès M; Buxó E; Fernández-Esparrach G; Colletti PM; Rubello D; Mayoral M; Sánchez N; Ruiz C; Ginés A; Fuster D
Clin Nucl Med; 2018 Jun; 43(6):402-410. PubMed ID: 29485442
[TBL] [Abstract][Full Text] [Related]
4. The peak-standardized uptake value (P-SUV) by preoperative positron emission tomography-computed tomography (PET-CT) is a useful indicator of lymph node metastasis in gastric cancer.
Oh HH; Lee SE; Choi IS; Choi WJ; Yoon DS; Min HS; Ra YM; Moon JI; Kang YH
J Surg Oncol; 2011 Oct; 104(5):530-3. PubMed ID: 21618250
[TBL] [Abstract][Full Text] [Related]
5. 18F-FLT PET/CT imaging is not competent for the pretreatment evaluation of metastatic gastric cancer: a comparison with 18F-FDG PET/CT imaging.
Zhou M; Wang C; Hu S; Zhang Y; Yao Z; Li J; Guo W; Zhang Y
Nucl Med Commun; 2013 Jul; 34(7):694-700. PubMed ID: 23604223
[TBL] [Abstract][Full Text] [Related]
6. The value of FDG-PET in the staging of gastric adenocarcinoma: A single institution retrospective review.
Serrano OK; Love C; Goldman I; Huang K; Ng N; Abraham T; Da Silva R; Friedmann P; Libutti SK; Kennedy TJ
J Surg Oncol; 2016 May; 113(6):640-6. PubMed ID: 27115836
[TBL] [Abstract][Full Text] [Related]
7. Evaluation of 18F-FDG uptake for detecting lymph node metastasis of gastric cancer: a prospective pilot study for one-to-one comparison of radiation dose and pathological findings.
Okumura Y; Aikou S; Onoyama H; Jinbo K; Yamagata Y; Mori K; Yamashita H; Nomura S; Takahashi M; Koyama K; Momose T; Abe H; Matsusaka K; Ushiku T; Fukayama M; Seto Y
World J Surg Oncol; 2015 Dec; 13():327. PubMed ID: 26628257
[TBL] [Abstract][Full Text] [Related]
8. Lymph node staging of gastric cancer using (18)F-FDG PET: a comparison study with CT.
Yun M; Lim JS; Noh SH; Hyung WJ; Cheong JH; Bong JK; Cho A; Lee JD
J Nucl Med; 2005 Oct; 46(10):1582-8. PubMed ID: 16204706
[TBL] [Abstract][Full Text] [Related]
9. Response to chemotherapy in gastric adenocarcinoma with diffusion-weighted MRI and (18) F-FDG-PET/CT: correlation of apparent diffusion coefficient and partial volume corrected standardized uptake value with histological tumor regression grade.
Giganti F; De Cobelli F; Canevari C; Orsenigo E; Gallivanone F; Esposito A; Castiglioni I; Ambrosi A; Albarello L; Mazza E; Gianolli L; Staudacher C; Del Maschio A
J Magn Reson Imaging; 2014 Nov; 40(5):1147-57. PubMed ID: 24214734
[TBL] [Abstract][Full Text] [Related]
10. Improvement in preoperative staging of gastric adenocarcinoma with positron emission tomography.
Chen J; Cheong JH; Yun MJ; Kim J; Lim JS; Hyung WJ; Noh SH
Cancer; 2005 Jun; 103(11):2383-90. PubMed ID: 15856477
[TBL] [Abstract][Full Text] [Related]
11. A prospective evaluation of the utility of 2-deoxy-2-[(18) F]fluoro-D-glucose positron emission tomography and computed tomography in staging locally advanced gastric cancer.
Smyth E; Schöder H; Strong VE; Capanu M; Kelsen DP; Coit DG; Shah MA
Cancer; 2012 Nov; 118(22):5481-8. PubMed ID: 22549558
[TBL] [Abstract][Full Text] [Related]
12. Progressing Sclerosing Mesenteritis (Mesenteric Panniculitis) Mimics Progression of Malignancy After Neoadjuvant Chemotherapy for Gastric Adenocarcinoma on Serial 18F-FDG PET/CT.
Makis W
Clin Nucl Med; 2016 Apr; 41(4):313-6. PubMed ID: 26359565
[TBL] [Abstract][Full Text] [Related]
13. Performance of (18)F-FDG PET/CT as a postoperative surveillance imaging modality for asymptomatic advanced gastric cancer patients.
Lee DY; Lee CH; Seo MJ; Lee SH; Ryu JS; Lee JJ
Ann Nucl Med; 2014 Oct; 28(8):789-95. PubMed ID: 24965850
[TBL] [Abstract][Full Text] [Related]
14. Predictive value of pretreatment metabolic activity measured by fluorodeoxyglucose positron emission tomography in patients with metastatic advanced gastric cancer: the maximal SUV of the stomach is a prognostic factor.
Park JC; Lee JH; Cheoi K; Chung H; Yun MJ; Lee H; Shin SK; Lee SK; Lee YC
Eur J Nucl Med Mol Imaging; 2012 Jul; 39(7):1107-16. PubMed ID: 22526958
[TBL] [Abstract][Full Text] [Related]
15. 18F-FDG PET/CT of Primary Mediastinal Hepatoid Adenocarcinoma.
Hu N; Tan Y; Luo J; Cheng Z; Wang Y
Clin Nucl Med; 2016 Apr; 41(4):321-2. PubMed ID: 26914554
[TBL] [Abstract][Full Text] [Related]
16. Relationship Between 18F-FDG PET/CT Findings and HER2 Expression in Gastric Cancer.
Chen R; Zhou X; Liu J; Huang G
J Nucl Med; 2016 Jul; 57(7):1040-4. PubMed ID: 26966162
[TBL] [Abstract][Full Text] [Related]
17. Hepatoid adenocarcinoma of the stomach: dual-time-point (18)F-FDG PET/CT findings.
Sun X; Li Y; Dong M; Li W; Xing L
Jpn J Radiol; 2014 Dec; 32(12):721-4. PubMed ID: 25287326
[TBL] [Abstract][Full Text] [Related]
18. [Clinical value of (18)F-FDGPET/CT in differentiation between benign lesions and lung cancer for large shadows in patients with pneumoconiosis].
Wang Y; Zhang H; Cui X; Fang N; Zeng L; Zhang C
Zhonghua Lao Dong Wei Sheng Zhi Ye Bing Za Zhi; 2014 Mar; 32(3):186-9. PubMed ID: 24641846
[TBL] [Abstract][Full Text] [Related]
19. Hyperaccumulation of (18)F-FDG in order to differentiate solid pseudopapillary tumors from adenocarcinomas and from neuroendocrine pancreatic tumors and review of the literature.
Guan ZW; Xu BX; Wang RM; Sun L; Tian JH
Hell J Nucl Med; 2013; 16(2):97-102. PubMed ID: 23687644
[TBL] [Abstract][Full Text] [Related]
20. Preoperative lymph-node staging of invasive urothelial bladder cancer with 18F-fluorodeoxyglucose positron emission tomography/computed axial tomography and magnetic resonance imaging: correlation with histopathology.
Jensen TK; Holt P; Gerke O; Riehmann M; Svolgaard B; Marcussen N; Bouchelouche K
Scand J Urol Nephrol; 2011 Mar; 45(2):122-8. PubMed ID: 21231796
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]